ABT Abbott Laboratories logo

ABT Abbott Laboratories

Healthcare
$87.41-0.41%ClosedMarket Cap: $152.25B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

26.72

PEG

P/B

2.93

P/S

3.37

EV/EBITDA

16.61

DCF Value

$143.01

FCF Yield

4.8%

Div Yield

2.8%

Margins & Returns

Gross Margin

56.4%

Operating Margin

18.2%

Net Margin

13.9%

ROE

12.2%

ROA

5.7%

ROIC

6.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$11.16B$1.08B$
Q4 null$11.46B$1.78B$
FY null$44.33B$6.52B$
Q3 null$11.37B$1.64B$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$127.46

Target (Median)

$125.00

Target Range

$92.00 - $152.00

5 Strong Buy16 Buy7 Hold0 Sell0 Strong Sell
BTIGBuy
2026-04-27
BarclaysOverweight
2026-04-20
B of A SecuritiesBuy
2026-04-17
Piper SandlerOverweight
2026-04-17
RBC CapitalOutperform
2026-04-17

Trading Activity

Insider Trades

View All
Moreland Mary Kofficer: EXECUTIVE VICE PRESIDENT
SellWed Apr 29
Stratton John Gdirector
SellTue Apr 28
STARKS DANIEL Jdirector
BuyTue Apr 28
STARKS DANIEL Jdirector
SellTue Apr 28
STARKS DANIEL Jdirector
SellTue Apr 28

Congress Trades

View All
Laura FriedmanSell
Mon Apr 20
Michael McCaulSell
Fri Apr 10
Rich McCormickBuy
Wed Apr 08

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.65

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Peers